Search This Blog

Showing posts with label Blood Disorder Drugs Market Report. Show all posts
Showing posts with label Blood Disorder Drugs Market Report. Show all posts

Sep 14, 2018

Increased Use Of Tranexamic Acid To Prevent Postpartum Hemorrhage In The Global Hematology Drugs Market (Companies Included: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., Pfizer Inc.)


Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.

Read more at:

The global hematology drugs market has been growing in the past years with a CAGR of almost 6%. The year 2017 recorded high growth in this market with a net market value more than 21% higher than that of 2013, as per TBRC’s in-house consultants.

TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.

The report also shows the global hematology drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.

Sample report:

Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%.


Companies included in the report are Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., and Pfizer Inc.

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Jul 3, 2018

Global Hematology Drugs Market Is Expected To Grow By $52 Billion By 2021 According To TBRC’s Latest Report


Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.

Read the report at
The substantial growth of the market from $40 billion in 2017 to around $52 billion by 2021 is due to the unhealthy lifestyle of consumers leading to anemia and coagulation disorders. Factors such as increased longevity and the launch of pipeline drugs will also drive the market for hematology drugs.
In the report, the hematology drugs market is divided into blood products and anemia and other blood disorder drugs, with blood products occupying the major market share (nearly 70%) and remaining is occupied by anemia and other blood products.

Download a sample of the report at
The USA was the largest country in the hematology drugs market in 2017, accounting for 30% of the market share. This was mainly due to high drug prices and high healthcare spending in the USA compared to other countries. China and Brazil followed the USA as the next largest countries in the market.
The hematology drugs market is fragmented with a number of large and small organizations. The top five competitors in the market made up around 25% of the total market in 2017. Novo Nordisk A/S was the largest competitor followed by Shire Plc., Bayer AG, Daiichi Sankyo Company Limited and Biogen Inc. Novo Nordisk A/S is a healthcare company involved in discovering, developing, manufacturing, and marketing of pharmaceutical products. Novo Nordisk markets and distributes its products through distributors and independent agents worldwide.

About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293